Literature DB >> 22245902

Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study.

Gustavo Pereira1, Mónica Guevara, Claudia Fagundes, Elsa Solá, Ezequiel Rodríguez, Javier Fernández, Marco Pavesi, Vicente Arroyo, Pere Ginès.   

Abstract

BACKGROUND & AIMS: Skin and soft tissue infection in cirrhosis is considered a non-severe infection, but specific information is lacking. This study aimed at assessing the characteristics, occurrence of renal failure, and outcome of cirrhotic patients with skin and soft tissue infection.
METHODS: Ninety-two patients with cirrhosis and skin and soft tissue infection admitted to hospital within a 6-year period were retrospectively analyzed. A control group matched by severity of liver disease, admitted for reasons other than infection, was also studied.
RESULTS: Resolution of the infection was achieved in 96% of patients. Twenty (21.7%) patients with skin and soft tissue infection developed renal failure, compared to only five patients (5.4%) of the control group (p=0.001). Renal failure was persistent despite infection resolution in 10 of the 20 patients vs. none of the control group. Renal failure was associated with poor prognosis. Hyponatremia developed in 40% and 25% of the infection and control group, respectively (p=0.028). Within a 3-month follow-up period, 25 patients (23%) with skin and soft tissue infection died or were transplanted compared to only four patients (4%) of the control group (p<0.001). Factors independently associated with mortality in the infection group were: site of acquisition of the infection and MELD-sodium score at diagnosis.
CONCLUSIONS: Skin and soft tissue infection is a severe complication of cirrhosis with high frequency of renal failure and hyponatremia that may persist despite resolution of the infection. MELD-sodium score is useful to assess 3-month mortality in these patients. Copyright Â
© 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22245902     DOI: 10.1016/j.jhep.2011.11.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Management of hyponatremia in clinical hepatology practice.

Authors:  Paul Y Kwo
Journal:  Curr Gastroenterol Rep       Date:  2014

Review 2.  Approach to Hyponatremia in Cirrhosis.

Authors:  Bashar Attar
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-04-30

Review 3.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

4.  Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume.

Authors:  Timi Edeki; Mirjana Kujacic; Helen Broadhurst; Jianguo Li; Maria Sunzel
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

Review 5.  Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.

Authors:  G Liamis; T D Filippatos; A Liontos; M S Elisaf
Journal:  Hepatol Int       Date:  2016-06-21       Impact factor: 6.047

6.  Impact of Hyponatremia on Morbidity, Mortality, and Resource Utilization in Portal Hypertensive Ascites: A Nationwide Analysis.

Authors:  Paul J Thuluvath; Joseph J Alukal; Talan Zhang
Journal:  J Clin Exp Hepatol       Date:  2021-10-28

Review 7.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 8.  KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-07-09

9.  Hyponatraemia and cirrhosis.

Authors:  Robert J Gianotti; Andres Cardenas
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-01-21

Review 10.  Hyponatremia in Infectious Diseases-A Literature Review.

Authors:  Anna L Królicka; Adrianna Kruczkowska; Magdalena Krajewska; Mariusz A Kusztal
Journal:  Int J Environ Res Public Health       Date:  2020-07-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.